TORONTO, Dec. 2, 2021 /CNW/ – Mimi’s Rock Corp., (the “Firm“) (TSXV: MIMI) (OTCQB: MIMNF) in the present day introduced its plan to develop into the Center East by means of a brand new partnership with UltraPharma, a licensed pharmaceutical distribution firm situated in Dubai, United Arab Emirates reaching extra customers with prime manufacturers Dr. Tobias well being dietary supplements and skincare All Pure Recommendation and Maritime Naturals.
UltraPharma’s multichannel advertising and distribution community allows prospects within the Center East to entry and buy a variety of merchandise supplied by Mimi’s Rock. Up to now decade, the Center Japanese market demonstrated sturdy progress in health-conscious customers who’re searching for prime quality, genuine nutritional vitamins, dietary supplements and sweetness merchandise. UltraPharma has over 25 years of expertise within the UAE and are famend for utilizing tailor-made content material that speaks the language of Mimi’s Rock viewers. By way of UltraPharma’s relationship with prime eCommerce channels – Amazon, Midday, Mumzworld and FITAMINAT – Mimi’s Rock’s stock will instantly attain a large viewers in preparation for 2022 objectives.
Mimi’s Rock’s first cargo of Dr. Tobias well being dietary supplements will attain the United Emirates in time for vacation buying and might be bought on-line by means of a number of marketplaces on the onset to fulfill the calls for of customers throughout the nation. Adopted by All Pure Recommendation and Maritime Naturals to be obtainable by the brand new yr.
“Increasing Mimi’s Rock proprietary complement, nutraceutical and sweetness care product manufacturers into new markets is a prime strategic precedence,” stated David Kohler, Chief Government Officer at Mimi’s Rock. “We’re assured our manufacturers are properly positioned to fulfill shopper calls for within the United Arab Emirates. With prime rated well being dietary supplements and sweetness care merchandise, we stay up for introducing them to high quality merchandise for which Mimi’s Rock manufacturers are recognized.”
Mimi’s Rock’s mission is to assist individuals be the most effective model of themselves and growth into markets comparable to China will assist the well being and wellness of individuals in every single place.
About UltraPharma:
UltraPharma is a Ministry of Well being licensed pharmaceutical distribution firm situated in Dubai, United Arab Emirates. UltraPharma’s journey started in 1996 in Abu Dhabi as UltraMed; specializing in distribution of medical consumables and security merchandise for hospitals, laboratories and blood banks. In 2012, UltraMed expanded its operation to achieve the broader Center Japanese market by means of the inception of UltraPharma in Dubai. In 2019, UltraPharma launched its eCommerce website FITAMINAT, which gives prime quality well being and sweetness merchandise and over two dozen manufacturers – together with Sambucol, Biolgan, and Haliborange.
About Mimi’s Rock Corp.:
Mimi’s Rock Corp. is an internet dietary complement and wellness firm which market and sells its merchandise below the Dr Tobias, All Pure Recommendation and Maritime Naturals model names. The Dr Tobias model options over 30 merchandise, together with the top-selling Colon 14-Day Cleanse and the #1 promoting Omega 3 Fish Oil on Amazon.com. All Pure Recommendation and Maritime Naturals merchandise deal with pores and skin and sweetness care. Merchandise bought below the All Pure and Maritime Naturals model names are made in Canada and registered with Well being Canada and below the EU Cosmetics Act. All Pure Recommendation has been featured on BNN as a prime promoting skincare model in Canada, and has been rated the #1 Magnificence Model on Amazon Canada for the previous 4 years.
Ahead-Trying Statements
This information launch accommodates forward-looking statements and forward-looking data throughout the which means of relevant securities legal guidelines. Typically, however not at all times, forward-looking statements might be recognized by way of phrases comparable to “plans”, “expects”, or “doesn’t anticipate”, “is predicted”, “finances”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “doesn’t anticipate”, or “believes”, or describes a “purpose”, or variation of such phrases and phrases or state that sure actions, occasions or outcomes “could”, “might”, “would”, “may” or “will” be taken, happen or be achieved. Please discuss with the 2020 Annual Monetary Statements for extra particulars on the Firm’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements mirror the Firm’s beliefs and assumptions based mostly on data obtainable on the time the statements have been made. Precise outcomes or occasions could differ from these predicted in these forward-looking statements. All the Firm’s forward-looking statements are certified by the assumptions which can be said or inherent in such forward-looking statements, together with the assumptions listed under. Though the Firm believes that these assumptions are cheap, this listing shouldn’t be exhaustive of things which will have an effect on any of the forward-looking statements.
Though the Firm has tried to determine necessary components that might trigger precise actions, occasions or outcomes to vary materially from these described in forward-looking statements, there could also be different components that trigger actions, occasions or outcomes to not be as anticipated, estimated or supposed. There might be no assurance that forward-looking statements will show to be correct, as precise outcomes and future occasions might differ materially from these anticipated in such statements. Accordingly, readers mustn’t place undue reliance on forward-looking statements. All forward-looking data contained on this press launch is given as of the date hereof and is predicated upon the opinions and estimates of administration and knowledge obtainable to administration as on the date hereof. The Firm disclaims any intention or obligation to replace or revise any forward-looking statements whether or not because of new data, future occasions, or in any other case, besides in accordance with relevant securities legal guidelines.
Please go to www.mimisrock.com or www.sedar.com for the Firm’s current filings.
Neither the TSX Enterprise Alternate nor its Regulation Providers Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Alternate) accepts duty for the adequacy or accuracy of this information launch.
SOURCE Mimi’s Rock Corp.
For additional data: David Kohler – CEO, 905-330-5081, [email protected]; Invoice Mitoulas – Investor Relations, 416-479-9547, [email protected]
